Adia Med Inc.
Other OTCRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Adia Nutrition, Inc. (OTCQB: ADIA) develops and markets nutritional supplements and advanced medical treatments focused on regenerative healthcare and wellness. The company operates through a supplement division offering premium probiotic drink mixes including balanced berry, unsweetened green tea, raspberry lemonade slim, lemon lime sport, and orange mango flavors; probiotic chews in berry and lemonade varieties; and functional beverages such as Biolete protein coffee infused with adaptogens and mushrooms like Cordyceps, Reishi, Lion's Mane, Shiitake, and Turkey Tail for energy, focus, mood enhancement, muscle recovery, and anti-inflammatory benefits; and a medical division providing autologous hematopoietic stem cell transplantation (aHSCT) for multiple sclerosis, therapeutic plasma exchange (TPE), stem cell therapies, platelet-rich plasma (PRP) injections, orthopedic and pain management services, and wound repair through Adia Med clinics. Products are sold online, through nutrition stores, and via AdiaVita and AdiaLink branded HCT/Ps; services target consumers, healthcare providers, and patients with chronic conditions across the United States with nationwide clinic expansion. Founded in 1999 and headquartered in Winter Park, Florida, the company formerly known as PivX Solutions Inc. changed its name in May 2004. Recent developments include the acquisition of Biolete to enter the functional beverage market; a strategic partnership with Cement Factory Nutrition co-owned by former WWE wrestler Jeff Sciullo to diversify supplements; a $500,000 line of credit from CEO Larry Powalisz for aHSCT clinic growth; partnerships with Aetna (effective July 2025) and pending United Healthcare inclusion to access millions of insured patients for regenerative therapies; a request to update its SIC code to 2836 for biological products reflecting stem cell and biologic advancements; filing of a patent application for regenerative medicine protocols via AdiaLabs LLC; and rapid sales force tripling for U.S. and global expansion.
Adia Med Inc. (Formerly Adia Nutrition Inc.) Launches Redesigned Corporate Website
Adia Med's Rise, Highlighting 2.5 Years of Growth Toward NASDAQ
Adia Nutrition to Trade as Adia Med Inc. After Lightning-Fast FINRA Review
Adia Nutrition Inc. Enters FINRA Home Stretch for Corporate Name Change to Adia Med Inc.
Adia Med Finds Another Unicorn
Adia Med Improves Quality of Care with Advanced Ultrasound-Guided IV Training
Adia Nutrition Inc. Delivers Exciting Update: Name Change to Adia Med Inc. Now Official in Nevada
Adia Nutrition Launches Dynamic New Subsidiary ADIA Life LLC in Florida to Supercharge Distribution and Unlock a Full Spectrum of Life-Transforming Wellness Solutions
Adia Nutrition, Inc. Drops Explosive Sneak Peek of Upcoming Documentary Featuring TNA Wrestling Star Jeff Sciullo (Elias)
Adia Nutrition Announces Expanded Stem Cell Coverage Through Independent Monthly-Membership Health Care Sharing Ministry
Adia Med Now Recruiting for Kidney Health and Lower Back Pain Studies Listed on ClinicalTrials.gov
ADIA Nutrition, Inc. Reports Strong Revenue Growth and Operational Momentum for First Quarter 2026
ADIA Nutrition Announces IRB Approval of All Four Clinical Studies and Registration of Kidney Health Study on ClinicalTrials.gov
Adia Nutrition Announces IRB Approval and ClinicalTrials.gov Submission for Groundbreaking Stem Cell Study in Chronic Kidney Disease (CKD)
Adia Nutrition Announces Three Pivotal Clinical Studies Receive Major IRB Milestone - Final Approval Now Clearly in Sight
Adia Nutrition, Inc. Announces Corporate Name Change to Adia Med, Inc. to Better Align with Its Regenerative Medicine and Biologics Business Model
Adia Nutrition Strikes Major Partnership with Leading Atlanta Clinic to Launch Groundbreaking Autism Clinical Study
Adia Nutrition, Inc. Reports Strong Revenue Growth in 2025 Annual Report, Highlighting Transition to Regenerative Medicine and Full SEC Reporting Status
Tonight: Adia Nutrition and UCF CARD Host Live Zoom on Revolutionary Stem Cell Study for Autism - Strong Interest Already Building
Adia Med of Winter Park Appoints Amy Dalrymple, APRN, Former Mrs. Florida United States, to Lead Regenerative Aesthetics Division